Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

WDR26 and MTF2 are therapeutic targets in multiple myeloma

Journal of Hematology & Oncology(2021)10.1186/s13045-021-01217-9Source: DataRank Database

WDR26 and MTF2 are therapeutic targets in multiple myeloma is a research paper published in Journal of Hematology & Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: goldTopics (29)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Yan Cheng ORCID,Jesse D. Riordan ORCID,Adam J. Dupuy ORCID,Wendy Dubois,Michael Pisano

Live enrichment

PubMed:34876184 PMC:PMC8650373

National Cancer Institute

Grant: R01CA151354

National Cancer Institute

Grant: R01CA236814

DOD Peer Reviewed Cancer Research Program

Grant: CA180190

NCI NIH HHS

Grant: R41 CA180190

NCI NIH HHS

Grant: R42 CA180190

National Institutes of Health

Grant: 3R01CA236814-03S1

Novel NEK2 signaling pathways in myeloma progression - Bauer Diversity Supplement

National Institutes of Health

Grant: 7R01CA151354-08

Biological Validation of Candidate Myeloma Driver Genes

goldLicense: CC BY

publisherhttps://link.springer.com/content/pdf/10.1186/s13045-021-01217-9.pdf

publisherhttps://link.springer.com/article/10.1186/s13045-021-01217-9/fulltext.html

Unpaywallhttps://jhoonline.biomedcentral.com/track/pdf/10.1186/s13045-021-01217-9

Europe_PMChttps://europepmc.org/articles/PMC8650373

Europe_PMChttps://europepmc.org/articles/PMC8650373?pdf=render

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsMice, TransgenicHumansMiceMultiple MyelomaAdaptor Proteins, Signal TransducingGene Expression Regulation, NeoplasticPolycomb Repressive Complex 2

Keywords

Forward Genetic ScreenMoloney Murine Leukemia VirusPolycomb Repressive Complex 2 (Prc2)Plasma Cell NeoplasiaCarboxy-Terminal To Lish (Ctlh) ComplexPolycomb Repressive Complex 2Neoplasms. Tumors. Oncology. Including cancer and carcinogensMice, TransgenicGene Expression Regulation, NeoplasticMiceAnimalsHumansDiseases of the blood and blood-forming organsRC633-647.5Multiple MyelomaLetter to the EditorRC254-282Adaptor Proteins, Signal Transducing

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 1 of WDR26 and MTF2 are therapeutic targets in multiple myeloma

10.6084/m9.figshare.17141203.v1figshare

Additional file 1 of WDR26 and MTF2 are therapeutic targets in multiple myeloma

10.6084/m9.figshare.17141203figshare

WDR26 and MTF2 are therapeutic targets in multiple myeloma

FAIR Checklist

Authors (11)

Funding (7 grants)

Open Access

Topics

Linked Datasets (2)

Annotations (Europe PMC)